Stable isotope resolved metabolomic differences between hormone-responsive and triple-negative breast cancer cell lines.
Intratumoral heterogeneity as a source of inter-laboratory disagreement in breast cancer biomarker classification
Racial Differences in PAM50 Subtypes in the Carolina Breast Cancer Study
Breast Cancer Subtype Important in Deciding Impact of Folate
February 1, 2017 • It is generally known that folate (vitamin B9) is important in early pregnancy to prevent neural tube defects in babies, because folate is needed by rapidly dividing cells (e.g., those of a developing embryo) for DNA synthesis and cellular energy production. As a consequence, many processed foods in the United States are fortified with […]
Anti-Inflammatory Diet May Fight Breast Cancer
March 28, 2016 • Promising work is underway in the laboratory of Dr. Stephen Hursting at the NRI to identify dietary interventions that can reduce the risk of cancer. Omega-3 fatty acids are well known anti-inflammatory dietary supplements. Because inflammation is associated with cancer, Hursting is investigating whether these supplements can reduce risk of developing cancer.
A joint analysis of metabolomics and genetics of breast cancer
“A joint analysis of metabolomics and genetics of breast cancer”. Tang X, Lin CC, Spasojevic I, Iversen ES, Chi JT, Marks JR (2014). Breast Cancer Res. 16(4): 415.
Dr. Hursting Awarded Grant from Breast Cancer Research Foundation
October 28, 2015 • The Breast Cancer Research Foundation seeks “to prevent and cure breast cancer by advancing the world’s most promising research.”Since 1993 BCRF-supported investigators have been deeply involved in every major advance in breast cancer prevention, diagnosis and treatment. In 2015-2016, BCRF is awarding $48.5 million in grants to more than 240 scientists to advance this work. Among those recipients is Stephen Hursting, Ph.D., M.P.H., Professor of Nutrition at the UNC Nutrition Research Institute.